CCL2 and glioblastoma: CCL1 mediates the migration of Tregs to SOX2+ breast cancer cells [188], and CCL2–CCR4 and CCL5CCR5 binding are responsible for the attraction of Tregs in glioblastoma and ovarian cancer, respectively [189,190].